You are here

  • Home
  • Archive
  • Volume 57, Issue 9
  • Two species of antiganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.

Article Text

Article menu
Download PDFPDF
Research Article
Two species of antiganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.
  1. K Mizoguchi,
  2. A Hase,
  3. T Obi,
  4. H Matsuoka,
  5. M Takatsu,
  6. Y Nishimura,
  7. F Irie,
  8. Y Seyama,
  9. Y Hirabayashi
  1. Department of Neurology, National Shizuoka Hospital, Japan.

    Abstract

    A patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome had anti-GT1a and anti-GD1a antibodies (IgG) in the serum. The activities of anti-GT1a antibodies were stronger than anti-GD1a antibodies and their activities declined later in the clinical course. These two different antibodies bound independently to each ganglioside in an absorption study with polystyrene beads coated with GT1a or GD1a.

    https://doi.org/10.1136/jnnp.57.9.1121

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      Linked Articles